Pedal Bcu, Llc

This early-stage trial is testing the safety and best dose of a new oral drug called ziftomenib when given alongside standard chemotherapy (FLA) to children and young adults. It is for patients aged 0-21 whose acute leukemia has come back or not responded to previous treatments. …

This study aims to find better treatments for children and young adults whose leukemia has returned or is hard to treat. It screens patients' blood and bone marrow to understand their specific cancer and match them to new, targeted therapy trials. The goal is to control the disea…

This study is testing if adding a pill called venetoclax to standard chemotherapy helps children and young adults whose acute myeloid leukemia (AML) has come back. It's for patients aged 29 days to 21 years whose cancer has relapsed once or twice. The main goal is to see if this …